Michael Kalb
Director of Finance/CFO chez CATALYST PHARMACEUTICALS, INC.
Postes actifs de Michael Kalb
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| CATALYST PHARMACEUTICALS, INC. | Director of Finance/CFO | 01/01/2024 | - |
Historique de carrière de Michael Kalb
Anciens postes connus de Michael Kalb
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| IPI LEGACY LIQUIDATION CO | Director of Finance/CFO | 10/05/2023 | 31/12/2023 |
| CINCOR PHARMA, INC. | Comptroller/Controller/Auditor | 04/11/2022 | 01/03/2023 |
| Director of Finance/CFO | 04/11/2022 | 01/03/2023 | |
| AMARIN CORPORATION PLC | Director of Finance/CFO | 30/06/2016 | 20/06/2022 |
| TARO PHARMACEUTICAL INDUSTRIES LTD. | Comptroller/Controller/Auditor | 15/11/2010 | 29/06/2016 |
| Director of Finance/CFO | 22/11/2010 | 29/06/2016 | |
| HURON CONSULTING GROUP INC. | Comptroller/Controller/Auditor | - | - |
Taro Pharmaceuticals U.S.A., Inc.
 Taro Pharmaceuticals U.S.A., Inc. Pharmaceuticals: GenericHealth Technology Part of Sun Pharmaceutical Industries Ltd., Taro Pharmaceuticals U.S.A., Inc. is a private company that manufactures and sells generic pharmaceutical products. The company is based in Hawthorne, NY. | Director of Finance/CFO | 01/06/2009 | - |
Formation de Michael Kalb
| State University of New York at Albany | Undergraduate Degree |
Statistiques
Internationale
| Etats-Unis | 7 |
| Irlande | 2 |
| Israël | 2 |
Opérationnelle
| Director of Finance/CFO | 6 |
| Comptroller/Controller/Auditor | 3 |
| Undergraduate Degree | 1 |
Sectorielle
| Health Technology | 7 |
| Commercial Services | 2 |
| Consumer Services | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Sociétés cotées | 5 |
|---|---|
| AMARIN CORPORATION PLC | Health Technology |
| TARO PHARMACEUTICAL INDUSTRIES LTD. | Health Technology |
| HURON CONSULTING GROUP INC. | Commercial Services |
| CATALYST PHARMACEUTICALS, INC. | Health Technology |
| IPI LEGACY LIQUIDATION CO | Health Technology |
| Entreprise privées | 2 |
|---|---|
Taro Pharmaceuticals U.S.A., Inc.
Taro Pharmaceuticals U.S.A., Inc. Pharmaceuticals: GenericHealth Technology Part of Sun Pharmaceutical Industries Ltd., Taro Pharmaceuticals U.S.A., Inc. is a private company that manufactures and sells generic pharmaceutical products. The company is based in Hawthorne, NY. | Health Technology |
CinCor Pharma, Inc.
 CinCor Pharma, Inc. Pharmaceuticals: MajorHealth Technology CinCor Pharma, Inc. operates as a clinical-stage biopharmaceutical company focused on developing its clinical candidate, CIN-107, for the treatment of hypertension and other cardio-renal diseases. The firm is developing CIN-107 for the treatment of multiple diseases where aldosterone plays a significant role in disease pathophysiology, including hypertension and primary aldosteronism, as well as its utility in ameliorating complications of chronic kidney disease. The company was founded by Jon Isaacsohn and Catherine Pearce on March 28, 2018 and is headquartered in Waltham, MA. | Health Technology |
- Bourse
- Insiders
- Michael Kalb
- Expérience
